Project Grant 2051417
Award Date 7/1/21
Completion Date 12/31/21
Dollars Obligated $255K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dover, DE 19904, USA
Similar Awards
- This Project Grant award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $274,946 to Free To Feed, Inc. to develop a real-time, at-home allergen detection test for human milk. The goal is to provide a rapid and cost-effective solution to determine the allergen content of human milk, addressing the issue that up to 25% of infants have reported allergic responses to proteins found in breast milk, which can lead to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $250,000 Project Grant to the Regents of the University of Michigan on August 21, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research to develop diagnostic and prognostic tools for distinguishing the heterogeneity of allergic responses in food allergy patients. The research employs a novel synthetic immunological niche scaffold technology to...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Texas Medical Branch at Galveston a Project Grant of $429,499 under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 13, 2026, through January 31, 2031. This award funds the development and validation of AllergenAI, a novel machine learning tool designed to distinguish allergenic from non-allergenic proteins and identify potential...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $106,922 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 26, 2026, with a completion date of October 31, 2028. The award supports biomedical research investigating the mechanisms of food allergen absorption and anaphylaxis, with emphasis on identifying the role...
- The federal Project Grant award of $320,863 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research by Aaiit LLC (doing business as Inflammation Immuno Therapy) to develop a bifunctional IgE antagonist and dissociator (ANDI) drug that can dissociate IgE from mast cell receptors, thereby reducing asthmatic airway hyperreactivity. The research aims to build on the...
- This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
- The National Institute of Allergy and Infectious Diseases (NIAID), as part of the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), awarded a $300,000 Project Grant to Cellergy Pharma Inc. The grant, effective February 1, 2025 through January 31, 2027, supports the development of a bispecific antibody drug targeting IgE-producing B cells to treat severe allergic diseases. The key products and services to be delivered under this Phase I grant include: Determining the...
- Federal Project Grant Award Summary Aleutian Therapeutics, Inc. received a Project Grant award of $305,855 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 18, 2025, with a completion date of July 31, 2026. The award supports the development of a gene-edited platform technology designed to enable human allogeneic pluripotent stem cell (PSC)-based replacement therapies that can evade...
- The National Science Foundation awarded a $255,986 Project Grant to Arieca Inc. under the Engineering federal grant program (CFDA 47.041) for the period of February 1, 2021 through January 31, 2022. The grant funds research to develop a liquid metal-elastomer composite for electromagnetic shielding. The NSF Directorate for Engineering seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award supports those goals by funding...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Maryland, Baltimore $466,500 in Project Grant funding under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 1, 2026, with a completion date of January 31, 2031. This award supports a five-year research initiative investigating the relationship between gut microbial protein metabolism and response to peanut oral immunotherapy (POIT) in...
This Project Grant from the National Science Foundation Division of Industrial Innovation provided $255,331 to Alerje, Inc. to develop a food allergy management platform under the Engineering federal grant program (CFDA 47.041). The grant supported Alerje's work from July 1, 2021 through December 31, 2021 to advance its platform for improving food allergy diagnosis and treatment. As part of its mission to foster innovation in engineering, the NSF Engineering program aims to enhance economic strength and quality of life through supporting research and development like Alerje's efforts in this emerging area of food allergy management technology.
Generated 1/6/24, 2:26 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $255.3k | 6/30/21 |